FRANKLIN LAKES, N.J., Nov. 19 /PRNewswire/ -- Collagen Matrix, Inc. announced today that it has signed an agreement with Stryker Orthopaedics for the exclusive worldwide distribution of its NeuroMend(TM) Collagen Nerve Wrap.
NeuroMend is a resorbable, collagen-based rolled membrane matrix intended for use in the repair of crushed or severed peripheral nerves. NeuroMend provides a protective environment to guide the regeneration of the nerve across the injury or gap. The rolled membrane configuration of NeuroMend offers the ability of a single product to approximate nerves of varying diameters. In addition, NeuroMend can be implanted with minimal suturing due to the unique wrap design of the product.
"We are pleased to further our collaboration with Stryker Orthopaedics in the area of nerve repair. Stryker's highly-skilled and focused sales and marketing teams have already made a significant impact in the market with our Neuroflex and NeuroMatrix products. The addition of NeuroMend provides surgeons with a much needed solution for treating crush injuries often seen in trauma cases," said Shu-Tung Li, Ph.D., Founder and CEO of Collagen Matrix.
Stryker Corporation is one of the world's leading medical technology companies with a broad based range of products in orthopaedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives. The company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. Stryker also provides outpatient physical therapy services in the United States. The company's website address is http://www.stryker.com.
Collagen Matrix, Inc. is a leader in the design and engineering of collagen- and mineral-based extracellular matrices for tissue and organ repair and regeneration. Since its inception in 1997, the Company has received many government grants for the development of collagen-based matrix products in the areas of neurological, vascular, urological, and orthopedic tissue regeneration applications. The Company currently manufactures collagen- and mineral-based finished medical devices in the areas of neurosurgery, oral surgery, orthopedic-spine surgery, and wound care. More information about the Company can be found at www.collagenmatrix.com.
Contact: Shu-Tung Li, Ph.D. 888-405-1001, 201-405-1477
CONTACT: Shu-Tung Li, Ph.D. 888-405-1001, 201-405-1477
Web site: http://www.collagenmatrix.com/